Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience
- 1 July 2022
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 51 (1) , 193-201
Abstract
Purpose The diagnosis of pulmonary blastomycosis is usually delayed because of its non-specific presentation. We aimed to assess the extent of diagnostic delay in hospitalized patients and detect the step in the diagnostic process that requires the most improvement. Methods Adult patients diagnosed with pulmonary blastomycosis during a hospital admission between January 2010 through November 2021 were eligible for inclusion. Patients who did not have pulmonary involvement and who were diagnosed before admission were excluded. Demographics and comorbid conditions, specifics of disease presentation, and interventions were evaluated. The timing of the diagnosis, antifungal treatment, and patient outcomes were noted. Descriptive analytical tests were performed. Results A total of 43 patients were diagnosed with pulmonary blastomycosis during their admissions. The median age was 47 years, with 13 (30%) females. Of all patients, 29 (67%) had isolated pulmonary infection, while 14 (33%) had disseminated disease, affecting mostly skin and musculoskeletal system. The median duration between the initial symptoms and health care encounters was 4 days, and the time to hospital admission was 9 days. The median duration from the initial symptoms to the diagnosis was 20 days. Forty patients (93%) were treated with empirical antibacterials before a definitive diagnosis was made. In addition, corticosteroid treatment was empirically administered to 15 patients (35%) before the diagnosis, with indications such as suspicion of inflammatory processes or symptom relief. In 38 patients (88%), the first performed fungal diagnostic test was positive. Nineteen patients (44%) required admission to the intensive care unit, and 11 patients (26%) died during their hospital stay. Conclusion There was a delay in diagnosis of patients with pulmonary blastomycosis, largely attributable to the lack of consideration of the etiological agent. Novel approaches to assist providers in recognizing the illness earlier and trigger evaluation are needed.Keywords
This publication has 25 references indexed in Scilit:
- Endemic mycoses: Overlooked causes of community acquired pneumoniaRespiratory Medicine, 2012
- Clinical and economic burden of community-acquired pneumonia among adults in EuropeThorax, 2010
- Corticosteroids as Adjunctive Therapy in Severe Blastomycosis‐Induced Acute Respiratory Distress Syndrome in an Immunosuppressed PatientClinical Infectious Diseases, 2010
- Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literatureBMC Infectious Diseases, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2008
- Corticosteroids for Blastomycosis-Induced ARDSChest, 2008
- The Epidemiology of Blastomycosis in Illinois and Factors Associated with DeathClinical Infectious Diseases, 2005
- Pulmonary BlastomycosisChest, 2002
- Clinical Presentation, Radiographic Findings, and Diagnostic Methods of Pulmonary BlastomycosisSouthern Medical Journal, 1999